Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 117
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Diagnostic Radiopharmaceuticals & Contrast Media market size was valued at USD 10060 million in 2023 and is forecast to a readjusted size of USD 12380 million by 2030 with a CAGR of 3.0% during review period.
The Global Info Research report includes an overview of the development of the Diagnostic Radiopharmaceuticals & Contrast Media industry chain, the market status of Hospital (Radiopharmaceuticals, Contrast Media), Clinic (Radiopharmaceuticals, Contrast Media), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diagnostic Radiopharmaceuticals & Contrast Media.
Regionally, the report analyzes the Diagnostic Radiopharmaceuticals & Contrast Media markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diagnostic Radiopharmaceuticals & Contrast Media market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Diagnostic Radiopharmaceuticals & Contrast Media market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diagnostic Radiopharmaceuticals & Contrast Media industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Radiopharmaceuticals, Contrast Media).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diagnostic Radiopharmaceuticals & Contrast Media market.
Regional Analysis: The report involves examining the Diagnostic Radiopharmaceuticals & Contrast Media market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diagnostic Radiopharmaceuticals & Contrast Media market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Diagnostic Radiopharmaceuticals & Contrast Media:
Company Analysis: Report covers individual Diagnostic Radiopharmaceuticals & Contrast Media manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diagnostic Radiopharmaceuticals & Contrast Media This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Diagnostic Radiopharmaceuticals & Contrast Media. It assesses the current state, advancements, and potential future developments in Diagnostic Radiopharmaceuticals & Contrast Media areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diagnostic Radiopharmaceuticals & Contrast Media market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Radiopharmaceuticals
Contrast Media
Market segment by Application
Hospital
Clinic
Other
Major players covered
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostic Radiopharmaceuticals & Contrast Media product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, with price, sales, revenue and global market share of Diagnostic Radiopharmaceuticals & Contrast Media from 2019 to 2024.
Chapter 3, the Diagnostic Radiopharmaceuticals & Contrast Media competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals & Contrast Media breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Diagnostic Radiopharmaceuticals & Contrast Media market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diagnostic Radiopharmaceuticals & Contrast Media.
Chapter 14 and 15, to describe Diagnostic Radiopharmaceuticals & Contrast Media sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Radiopharmaceuticals
1.3.3 Contrast Media
1.4 Market Analysis by Application
1.4.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size & Forecast
1.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (2019-2030)
1.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Amag Pharmaceuticals
2.1.1 Amag Pharmaceuticals Details
2.1.2 Amag Pharmaceuticals Major Business
2.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amag Pharmaceuticals Recent Developments/Updates
2.2 Bayer Healthcare
2.2.1 Bayer Healthcare Details
2.2.2 Bayer Healthcare Major Business
2.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Healthcare Recent Developments/Updates
2.3 Bracco Imaging
2.3.1 Bracco Imaging Details
2.3.2 Bracco Imaging Major Business
2.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bracco Imaging Recent Developments/Updates
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Daiichi Sankyo Recent Developments/Updates
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GE Healthcare Recent Developments/Updates
2.6 Guerbet
2.6.1 Guerbet Details
2.6.2 Guerbet Major Business
2.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Guerbet Recent Developments/Updates
2.7 Lantheus
2.7.1 Lantheus Details
2.7.2 Lantheus Major Business
2.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Lantheus Recent Developments/Updates
2.8 Mallinckrodt
2.8.1 Mallinckrodt Details
2.8.2 Mallinckrodt Major Business
2.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mallinckrodt Recent Developments/Updates
2.9 Medtronic
2.9.1 Medtronic Details
2.9.2 Medtronic Major Business
2.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Medtronic Recent Developments/Updates
2.10 Nordion
2.10.1 Nordion Details
2.10.2 Nordion Major Business
2.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nordion Recent Developments/Updates
3 Competitive Environment: Diagnostic Radiopharmaceuticals & Contrast Media by Manufacturer
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Manufacturer (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturer (2019-2024)
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Diagnostic Radiopharmaceuticals & Contrast Media by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share in 2023
3.4.2 Top 6 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share in 2023
3.5 Diagnostic Radiopharmaceuticals & Contrast Media Market: Overall Company Footprint Analysis
3.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market: Region Footprint
3.5.2 Diagnostic Radiopharmaceuticals & Contrast Media Market: Company Product Type Footprint
3.5.3 Diagnostic Radiopharmaceuticals & Contrast Media Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2019-2030)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2019-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Region (2019-2030)
4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030)
4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030)
4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030)
4.6 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
6.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application (2019-2030)
6.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Application (2019-2030)
7 North America
7.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
7.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
7.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
7.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2030)
7.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
8.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
8.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
8.3.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2030)
8.3.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region
9.3.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
10.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
10.3 South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
10.3.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2030)
10.3.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
11.3.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
12.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
12.3 Diagnostic Radiopharmaceuticals & Contrast Media Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Diagnostic Radiopharmaceuticals & Contrast Media and Key Manufacturers
13.2 Manufacturing Costs Percentage of Diagnostic Radiopharmaceuticals & Contrast Media
13.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Process
13.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Diagnostic Radiopharmaceuticals & Contrast Media Typical Distributors
14.3 Diagnostic Radiopharmaceuticals & Contrast Media Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Amag Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Amag Pharmaceuticals Major Business
Table 5. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 6. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Amag Pharmaceuticals Recent Developments/Updates
Table 8. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Healthcare Major Business
Table 10. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 11. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Healthcare Recent Developments/Updates
Table 13. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 14. Bracco Imaging Major Business
Table 15. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 16. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bracco Imaging Recent Developments/Updates
Table 18. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 19. Daiichi Sankyo Major Business
Table 20. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 21. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Daiichi Sankyo Recent Developments/Updates
Table 23. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. GE Healthcare Major Business
Table 25. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 26. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. GE Healthcare Recent Developments/Updates
Table 28. Guerbet Basic Information, Manufacturing Base and Competitors
Table 29. Guerbet Major Business
Table 30. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 31. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Guerbet Recent Developments/Updates
Table 33. Lantheus Basic Information, Manufacturing Base and Competitors
Table 34. Lantheus Major Business
Table 35. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 36. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Lantheus Recent Developments/Updates
Table 38. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 39. Mallinckrodt Major Business
Table 40. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 41. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mallinckrodt Recent Developments/Updates
Table 43. Medtronic Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Major Business
Table 45. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 46. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Medtronic Recent Developments/Updates
Table 48. Nordion Basic Information, Manufacturing Base and Competitors
Table 49. Nordion Major Business
Table 50. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 51. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Nordion Recent Developments/Updates
Table 53. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Diagnostic Radiopharmaceuticals & Contrast Media, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Diagnostic Radiopharmaceuticals & Contrast Media Production Site of Key Manufacturer
Table 58. Diagnostic Radiopharmaceuticals & Contrast Media Market: Company Product Type Footprint
Table 59. Diagnostic Radiopharmaceuticals & Contrast Media Market: Company Product Application Footprint
Table 60. Diagnostic Radiopharmaceuticals & Contrast Media New Market Entrants and Barriers to Market Entry
Table 61. Diagnostic Radiopharmaceuticals & Contrast Media Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Diagnostic Radiopharmaceuticals & Contrast Media Raw Material
Table 121. Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media Raw Materials
Table 122. Diagnostic Radiopharmaceuticals & Contrast Media Typical Distributors
Table 123. Diagnostic Radiopharmaceuticals & Contrast Media Typical Customers
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Picture
Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Type in 2023
Figure 4. Radiopharmaceuticals Examples
Figure 5. Contrast Media Examples
Figure 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Diagnostic Radiopharmaceuticals & Contrast Media by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Region (2019-2030)
Figure 53. China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
Figure 74. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
Figure 75. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals & Contrast Media in 2023
Figure 78. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 79. Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amag Pharmaceuticals Bayer Healthcare Bracco Imaging Daiichi Sankyo GE Healthcare Guerbet Lantheus Mallinckrodt Medtronic Nordion
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>